Research and discovery are a key part of Dell Medical School’s mission. Meet eight pairs of collaborators leading interdisciplinary teams to better health outcomes for Central Texas and beyond.

A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, according to a study by Dell Med neurologists.

From muscle weakness to poor sleep and vision problems — aging takes a toll on the body. New research at Dell Med will help meet the needs of older patients and shed light on how MS changes with age.

University of Texas researchers found that a five-day delay between identifying a case and isolating contacts was the Achilles’ heel of a contact tracing program in a large U.S. city.

Providing caregivers easy access to produce and flexible resources can lead to improvements in kids’ diets in a short time, according to a new study from Dell Med researchers.

The center will conduct clinical research to better understand the potential for drugs such as psilocybin, MDMA, ibogaine and ayahuasca to treat mental health disorders.

A Dell Med-U.S. Department of Veterans Affairs study showed that sexual assault and harassment could have a generational effect on military families.